3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
56
Carcinoma, Hepatocellular
43
Carcinoma, Non-Small-Cell Lung
23
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
18
Colorectal Neoplasms
18
Breast Neoplasms
17
Sarcoma
14
Neoplasms
14
Triple Negative Breast Neoplasms
13
Nasopharyngeal Carcinoma
11
Esophageal Squamous Cell Carcinoma
10
Cholangiocarcinoma
10
Osteosarcoma
9
Lung Neoplasms
9
Esophageal Neoplasms
9
Neoplasm Metastasis
8
Biliary Tract Neoplasms
8
Advanced Gastric Cancer
8
Uterine Cervical Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Recurrence
6
Pancreatic Neoplasms
6
Head and Neck Neoplasms
6
Thyroid Neoplasms
4
Solid Tumor
4
Melanoma
4
Liver Neoplasms
4
Glioma
4
Drug-Related Side Effects and Adverse Reactions
4
Interventions
sintilimab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Metastatic Gastric Cancer
×
apatinib
×
Clear all
NCT04089657
2019-09-13
ASGARD
Fujian Cancer Hospital
Phase 2
Unknown
40 enrolled